Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy

Increased Tuberculosis Reactivation Risk in Patients Receiving Immune Checkpoint Inhibitor-Based Therapy

Abstract Objective Reports of tuberculosis (TB) during anticancer treatment with immune checkpoint inhibitors (ICIs) are increasing. However, it is not clear whether the use of ICIs is a significant risk factor for TB, including reactivation or latent TB infection (LTBI). Methods To determine the ri...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Hsing-Wu Chen, Yao-Wen Kuo, Chung‐Yu Chen, Chin-Hao Chang, Sumei Wang, Ying‐Chun Chien, Wei‐Chen Lu, Jo‐Pai Chen, Cheng‐Yu Chang, Yu‐Feng Wei, Shih‐Chieh Chang, Chin‐Chung Shu, Jann‐Yuan Wang, Wei‐Yu Liao, Hao‐Chien Wang, Chong‐Jen Yu
Médium: Artigo
Jazyk:angličtina
Vydáno: 2024
On-line přístup:https://doi.org/10.1093/oncolo/oyad340
https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad340/56147999/oyad340.pdf
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Internet

https://doi.org/10.1093/oncolo/oyad340
https://academic.oup.com/oncolo/advance-article-pdf/doi/10.1093/oncolo/oyad340/56147999/oyad340.pdf

Podobné jednotky